<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Protac on Bioecon</title><link>https://en.bioecon.ru/technologies/protac/</link><description>Recent content in Protac on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 12:50:00 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/protac/index.xml" rel="self" type="application/rss+xml"/><item><title>PROTACs (targeted protein degradation)</title><link>https://en.bioecon.ru/technology/protacs/</link><pubDate>Sat, 11 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/protacs/</guid><description>Bifunctional small molecules that recruit an E3 ubiquitin ligase to a disease protein, tagging it for proteasomal destruction — an event-driven, catalytic drug modality approaching its first approval with Arvinas&amp;rsquo;s estrogen-receptor degrader vepdegestrant, and a deep pipeline across IRAK4, IKZF and BTK targets.</description></item></channel></rss>